2-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE | CAS:162046-61-9

We serve 2-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE CAS:162046-61-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE

Chemical Name:2-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE
CAS.NO:162046-61-9
Synonyms:2-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE
2-trifluoromethoxybenzoic acid chloride
Trifluoromethoxybenzoyl chloride
o-trifluoromethoxybenzoyl chloride
Molecular Formula:C8H4ClF3O2
Molecular Weight:224.56400
 
Physical and Chemical Properties:
Density:1.44
Boiling point:94ºC
Flash point:94-96ºC
Index of Refraction:1.47
 
Specification:
Appearance:Yellow transparent liquid
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,o-trifluoromethoxybenzoyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Trifluoromethoxybenzoyl chloride Use and application,Trifluoromethoxybenzoyl chloride technical grade,usp/ep/jp grade.


Related News: If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.2-((2-Nitro-4-(trifluoromethyl)phenyl)amino)ethanol manufacturer If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.1,12-Dodecanediol supplier If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.3-bromo-9-naphthalen-2-ylcarbazole vendor If the drug is in a syrup form, then the excipient is the liquid that has been used to make it as such.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.